Qun Chen

HDL-cholesterol confers sensitivity of immunotherapy in nasopharyngeal carcinoma via remodeling tumor-associated macrophages towards the M1 phenotype

F. Luo, J. Zhan, Yan Huang, 2024, Journal for ImmunoTherapy of Cancer.

The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation

Lin Zhang, F. Luo, J. Zhan, 2023, Cellular & molecular immunology.

Preclinical characterization and phase 1 results of ADG106 in patients with advanced solid tumors and non-Hodgkin’s lymphoma

W. Fang, Yuanyuan Zhao, F. Luo, 2024, Cell reports. Medicine.

PQR309, a dual PI3K/mTOR inhibitor, synergizes with gemcitabine by impairing the GSK-3β and STAT3/HSP60 signaling pathways to treat nasopharyngeal carcinoma

F. Luo, J. Zhan, Fei-Teng Lu, 2024, Cell death & disease.